Skip to main content
. 2025 Oct 10;14(10):1027. doi: 10.3390/pathogens14101027
ACE2 angiotensin converting enzyme 2
ADA anti-drug antibodies
Ang2 angiopoietin 2
CDR complementarity determining region
DAF dual action Fab
DMS deep mutational scanning
ELISA enzyme-linked immunosorbent assay
Fab antigen-binding fragments
HCDR heavy chain complementarity-determining region
HDR homology-directed repair
HLA human leukocyte antigen
IgG1 immunoglobulin G1
mAbs monoclonal antibodies
MHC major histocompatibility complex
PALs programmed allelic series
PCR polymerase chain reaction
PD-1 programmed cell death protein-1
RBD receptor binding domain
scFv single-chain variable fragments
SUNi scalable and uniform nicking mutagenesis
TCR T-cell receptor
TROP2 trophoblast cell surface antigen 2
TNF tumor necrosis factor
TP53 tumor protein p53
PBMC peripheral blood mononuclear cell
PTEN phosphatase and tensin homolog
VEGF vascular endothelial growth factor
VUS variants of uncertain significance